Christopher P. Lowe - 16 Nov 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role: COO & Chief Financial Officer
Signature: /s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Issuer symbol: QNCX
Transactions as of: 16 Nov 2021
Net transactions value: +$66,900
Form type: 4
Filing time: 16 Nov 2021, 19:17:52 UTC
Previous filing: 07 Oct 2021
Next filing: 05 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	QNCX	Common Stock	Options Exercise	$66,900	+30,000	+50%	$2.23	90,000	16 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QNCX	Stock Option (right to buy)	Options Exercise	$0	-30,000	-23%	$0.000000	103,294	16 Nov 2021	Common Stock	30,000	$2.23	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.